Hip Dysplasia: Clinical Trials

5 trials for Hip Dysplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 5

Follow Hip Dysplasia: new trials by email Literature Review of Hip Dysplasia trials Research Report on Hip Dysplasia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery
perineural Dexamethasone 4mg, intravenous Dexamethsone 4mg - Hip Dysplasia, Hip Disease
Phase 4CompletedPoznan University of Medical Sciences602025-02-012026-03-16
PENG Block vs. ESP Block for Pediatric Hip Surgery
Pericapsular nerve group block using 0.2% ropivacaine, Erector Spinae Plane Block using 0.2% ropivacaine, Standard care - Hip Dysplasia, Hip Injuries
Phase 4CompletedPoznan University of Medical Sciences902023-10-172024-02-28
Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy
Ropivacaine injection, normal saline - Cerebral Palsy, Hip Dysplasia
Phase 4CompletedUniversity of California, Los Angeles342019-12-012024-06-10
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase
Dexamethasone - Hip Dysplasia, Postoperative Complications
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet642017-04-242020-04-29
Hip Scope Fascia-iliaca (FI) Block Study
ropivicaine, clonidine, Epinephrine - Hip Dysplasia, Femoroacetabular Impingement
Phase 4CompletedThe Hawkins Foundation842015-04-012019-03-14

Narrower conditions

Hip Dislocation (5)  ·  Agnosia (1)  ·  Cerebral Palsy (1)  ·  Femoracetabular Impingement (1)  ·  Hip Fractures (1)  ·  Hip Injuries (1)  ·  Pain, Postoperative (1)  ·  Postoperative Complications (1)

Broader conditions

Joint Diseases (5)  ·  Joint Dislocations (5)  ·  Musculoskeletal Diseases (5)  ·  Wounds and Injuries (5)  ·  Hip Injuries (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Brain Damage, Chronic (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Femoral Fractures (1)  ·  Fractures, Bone (1)  ·  Leg Injuries (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)

Interventions

Epinephrine (2)  ·  Ropivacaine (2)  ·  Clonidine (1)  ·  Dexamethasone (1)  ·  Ketorolac (1)  ·  Saline Solution (1)  ·  Standard of Care (1)

Sponsors

Poznan University of Medical Sciences (2)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  The Hawkins Foundation (1)  ·  University of California, Los Angeles (1)

Countries

Poland (2)  ·  United States (2)  ·  Denmark (1)

Top investigators

Eugene Kim, MD (1)  ·  Malgorzata Reysner, M.D. Ph.D. (1)  ·  Rachel M Thompson, MD (1)  ·  Tomasz Kotwicki, Prof.dr hab (1)

Results publications

PMID 31999469, PMID 33399374